News Release Benchmarks for Healthcare/Biotech Industries

Onclusive & Business Wire team up to identify characteristics of a winning news release

In a first-of-its-kind research study, we analyzed 15,000 press releases in 2020 across two dozen industries to better understand how they affect generating syndicated pick-up, social media engagement and editorial coverage. The findings suggested the best days and times to distribute those releases, how broadly they should be distributed and in what format the releases should be sent.

To make these insights more actionable, we are launching a series of industry-specific benchmark reports. The first report focuses on the healthcare/biotechnology industries.

Watch this webinar to learn:

  • The most popular days and times to issue healthcare/biotech news and investor relations releases
  • The most effective days and times to issue news for generating syndicates, social media engagement and editorial coverage
  • Industry benchmarks for earned media sentiment
  • Expert recommendations and best practices for successful healthcare/biotech news and investor releases

View Webinar

Our panelists:

Dan Beltramo

CEO, Onclusive

Dan is the CEO of Onclusive, the data science company for communications and PR. Dan has over 20 years of leadership experience in the data and analytics industry. In 2005, Dan co-founded a digital media measurement firm, Vizu, that pioneered real time brand lift measurement. Vizu was bought by Nielsen in 2012 where Dan went on to become EVP of Product Leadership for all Marketing Effectiveness products globally.

Kena Hudson

Senior Vice President, FleishmanHillard San Francisco

Kena Hudson has more than 20 years of healthcare communications experience, spanning media relations, public affairs and crisis work. A former broadcast journalist, Hudson specializes in working with clients to build long-term communication plans and healthcare storytelling strategies that prioritize patients. Her work has focused on fields including medical devices, diagnostics, genomics, proteomics and cardiovascular and oncology therapies.

Ms. Hudson joined FleishmanHillard in December 2019 to help shape the strategy, at a senior level, for the San Francisco healthcare practice’s work with local, national and global healthcare organizations.

Contact Business Wire

Contact Us Today

Speak with a Business Wire representative for product, service, and pricing information. Set up an account and share your news.

Get Started